Skip to main content

Table 4 Propensity score analysis for LFS, OS, RI, NRM, GRFS, aGVHD II–IV, aGVHD III–IV, cGVHD, and ext. cGVHD

From: Unmanipulated haploidentical in comparison with matched unrelated donor stem cell transplantation in patients 60 years and older with acute myeloid leukemia: a comparative study on behalf of the ALWP of the EBMT

 

MUD

Haplo

p value

LFS

39.9% [34.7–45.1]

34.6% [27.9–41.3]

0.67

OS

42% [36.7–47.4]

38.7% [31.8–45.5]

0.33

RI

31.9% [27.2–36.7]

27.7% [21.7–34]

0.17

NRM

28.2% [23.6–32.9]

37.7% [31.1–44.3]

0.06

GRFS

24.8% [20.3–29.4]

30.2% [23.7–36.6]

0.15

aGVHD II-IV

33.1% [28.6–37.6]

30.5% [24.4–36.8]

0.28

cGVHD

40.6% [35.3–45.9]

26.5% [20.5–32.7]

0.24

ext cGVHD

20.5% [16.2–25.1]

10.7% [6.8–15.5]

0.041

  1. Abbreviations: LFS, leukemia free survival; OS, overall survival; RI, relapse incidence; NRM, non-relapse mortality; GRFS, graft-versus-host-free-relapse free survival; a, acute; c, chronic; GVHD, graft versus host disease; ext., extensive